Raia Drogasil S.A. RADLY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.19B | 2.01B | 2.24B | 2.07B | 1.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.19B | 2.01B | 2.24B | 2.07B | 1.78B |
| Cost of Revenue | 1.46B | 1.36B | 1.58B | 1.46B | 1.22B |
| Gross Profit | 731.99M | 644.65M | 660.12M | 608.91M | 553.42M |
| SG&A Expenses | 564.79M | 521.36M | 521.67M | 474.21M | 430.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.13M | 36.62M | -- | -- | 154.90K |
| Total Operating Expenses | 2.02B | 1.92B | 2.10B | 1.93B | 1.65B |
| Operating Income | 166.06M | 86.66M | 138.45M | 134.70M | 123.07M |
| Income Before Tax | 104.98M | 24.08M | 56.14M | 100.00M | 66.51M |
| Income Tax Expenses | 22.58M | -3.89M | 2.34M | 15.22M | 9.30M |
| Earnings from Continuing Operations | 82.40M | 27.97M | 53.80M | 84.78M | 57.22M |
| Earnings from Discontinued Operations | 1.64M | 2.22M | -- | -- | 10.36M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 2.66M | -1.42M | -1.58M |
| Net Income | 84.04M | 30.19M | 56.46M | 83.37M | 66.00M |
| EBIT | 166.06M | 86.66M | 138.45M | 134.70M | 123.07M |
| EBITDA | 207.48M | 125.90M | 188.37M | 169.12M | 158.87M |
| EPS Basic | 0.05 | 0.02 | 0.04 | 0.05 | 0.04 |
| Normalized Basic EPS | 0.04 | 0.01 | 0.03 | 0.03 | 0.02 |
| EPS Diluted | 0.05 | 0.02 | 0.04 | 0.05 | 0.04 |
| Normalized Diluted EPS | 0.04 | 0.01 | 0.03 | 0.03 | 0.02 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 1.55B | 1.68B | 1.68B |
| Average Diluted Shares Outstanding | 1.68B | 1.69B | 1.55B | 1.69B | 1.71B |
| Dividend Per Share | -- | -- | 0.03 | 0.01 | 0.01 |
| Payout Ratio | 58.02% | 0.31% | 112.92% | 0.02% | 82.42% |